System Transmission

Top Signal

100#1 JOB

Activity

2164Ripe

+918 today

System

Livenow

Terminal Asset View

stockNASDAQ

CCCC

$2.72-1.09%

C4 Therapeutics Inc

Neutral

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

13Neutral

Live Analysis Active

Company Mission

C4 Therapeutics creates targeted protein degradation drugs that aim to treat cancer by breaking down harmful proteins in cells. Pharmaceutical companies and research institutions partner with C4 to develop these treatments. The company makes money through research partnerships, licensing agreements, and hopes to earn revenue from future drug sales if their treatments receive FDA approval.

CCC

Industry Context

C4 Therapeutics operates in the biotechnology sector, specifically focusing on cancer treatment research. This industry experiences significant price movements based on clinical trial results, FDA approvals, and partnership announcements. Companies in this space often trade based on future potential rather than current revenue, making them sensitive to news about their research progress.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

39Matrix

Market Momentum

52.1— Holding Steady

Trend Strength

50— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.6x— Normal Volume

Today's Change

-1.09%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing CCCC across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 04:25 AM UTC

As-of 03-15-2026 04:09 UTC

Develops cancer drugs that target specific proteins and makes money by licensing treatments to pharmaceutical companies.

No recent price data available, suggesting limited trading activity which often precedes significant company announcements or clinical trial showing consolidation pattern.

Biotech sector showing increased volatility as FDA decisions approach, with companies like C4 needing to watch for clinical trial updates, suggesting.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...